With over 20 per cent year-on-year growth in revenues in June quarter, Cadila Healthcare, Sun Pharma and Lupin are most likely to lead the revenue growth of ten most valuable
Sun Pharma today said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it. In
BSE-listed Sun Pharmaceutical Industries got a reprieve from a US court as Pfizer-controlled Wyeth’s complaint on Protonix, an anti-ulcer drug, was thrown out. The US district court for the eastern
Birla Sun Life Asset Management, a part of the Aditya Birla Financial Services Group, is launching two seven-year real estate funds. These funds will invest in distressed real estate
A long wait by sky gazers to look at a rare celestial event will end tomorrow.
International Business Machines has lowered its offer price for Sun .
Stay informed on our latest news!
